Carly Hanna, Eva Morunga, Alesha Wells, Lisa M Reynolds
{"title":"Māori healthcare professionals' perceptions of psychedelic-assisted therapy: a qualitative study.","authors":"Carly Hanna, Eva Morunga, Alesha Wells, Lisa M Reynolds","doi":"10.26635/6965.6740","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Psychedelic-assisted therapies are gaining interest as an innovative treatment for problems with mental health and addictions, and there are several clinical trials in this area currently being conducted in Aotearoa New Zealand. However, many stakeholder groups hold concerns about cultural acceptability and safety. While psychedelic substances have a long history overseas in various Indigenous populations for spiritual and ritualistic purposes, their traditional use with Māori in Aotearoa New Zealand is unclear. Given our Te Tiriti o Waitangi obligations and the significant health inequities for Māori, any new treatments should be developed considering Te Ao Māori (Māori worldview) perspectives. This study aimed to explore Māori healthcare professionals' current awareness, attitudes and perspectives on psychedelics and psychedelic-assisted therapy.</p><p><strong>Methods: </strong>To explore these aims, 13 Māori healthcare professionals were recruited to participate in semi-structured qualitative interviews investigating psychedelic awareness, knowledge and attitudes using Māori health models Te Whare Tapa Whā and Te Wheke as a framework for data collection and analysis.</p><p><strong>Results: </strong>Four key themes were identified, including 1) greater awareness leads to greater openness towards psychedelic-assisted therapy (PAT), 2) more research and education about PAT is needed, 3) PAT has the potential to align with Te Ao Māori, and 4) equitable access is critical for Māori.</p><p><strong>Conclusion: </strong>Our sample of Māori healthcare professionals generally supported research investigating psychedelic therapies in Aotearoa New Zealand. Improving awareness of this novel treatment is likely to influence its acceptability as a treatment option and will inform the cultural safety of its use with Māori.</p>","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"138 1611","pages":"79-92"},"PeriodicalIF":1.2000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NEW ZEALAND MEDICAL JOURNAL","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26635/6965.6740","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: Psychedelic-assisted therapies are gaining interest as an innovative treatment for problems with mental health and addictions, and there are several clinical trials in this area currently being conducted in Aotearoa New Zealand. However, many stakeholder groups hold concerns about cultural acceptability and safety. While psychedelic substances have a long history overseas in various Indigenous populations for spiritual and ritualistic purposes, their traditional use with Māori in Aotearoa New Zealand is unclear. Given our Te Tiriti o Waitangi obligations and the significant health inequities for Māori, any new treatments should be developed considering Te Ao Māori (Māori worldview) perspectives. This study aimed to explore Māori healthcare professionals' current awareness, attitudes and perspectives on psychedelics and psychedelic-assisted therapy.
Methods: To explore these aims, 13 Māori healthcare professionals were recruited to participate in semi-structured qualitative interviews investigating psychedelic awareness, knowledge and attitudes using Māori health models Te Whare Tapa Whā and Te Wheke as a framework for data collection and analysis.
Results: Four key themes were identified, including 1) greater awareness leads to greater openness towards psychedelic-assisted therapy (PAT), 2) more research and education about PAT is needed, 3) PAT has the potential to align with Te Ao Māori, and 4) equitable access is critical for Māori.
Conclusion: Our sample of Māori healthcare professionals generally supported research investigating psychedelic therapies in Aotearoa New Zealand. Improving awareness of this novel treatment is likely to influence its acceptability as a treatment option and will inform the cultural safety of its use with Māori.